상세 보기
Phase 1 study of LY3866288, a potent, highly isoform-selective FGFR3 inhibitor in FGFR3-altered advanced solid tumors (FORAGER-1): Dose optimization
- Drakaki, Alexandra;
- Park, Se Hoon;
- Castellano, Daniel;
- Siefker-Radtke, Arlene;
- Reimers, Melissa A.;
- 외 16명
Citations
WEB OF SCIENCE
0- 제목
- Phase 1 study of LY3866288, a potent, highly isoform-selective FGFR3 inhibitor in FGFR3-altered advanced solid tumors (FORAGER-1): Dose optimization
- 저자
- Drakaki, Alexandra; Park, Se Hoon; Castellano, Daniel; Siefker-Radtke, Arlene; Reimers, Melissa A.; Gao, Xin; Rha, Sun Young; Galsky, Matthew D.; Tripathi, Abhishek; Sarfaty, Michal; Mamtani, Ronac; Zhang, Tian; Sonpavde, Guru; Vinceneux, Armelle; Loriot, Yohan; Garmezy, Benjamin; Szymczak, Sylwia; Zhao, Xiang; Widau, Ryan; Iyer, Gopa; Retz, Margitta
- 발행일
- 2026-02
- 유형
- Meeting Abstract
- 권
- 49
- 페이지
- 297 ~ 297